Clinical Research Directory

Inclusion criteria: 15 patients divided in : * 7 patients with favourable intermediate risk prostate cancer (cT2b or Gleason score 7 (3+4) or PSA value 10-20 ng/mL, Briganti 5-20%,) * 8 patients with unfavourable intermediate risk prostate cancer (cT2b or Gleason score 7 (4+3) or PSA value 10-20 ng/mL, Briganti 5-20%,) * who are candidate for radical prostatectomy after discussion in multidisciplinary committee * covered by the national health insurance system * with freely written informed consent obtained Exclusion criteria: * Any kind of previous treatment for prostate cancer (hormonal treatment, EBRT, brachytherapy, cryotherapy, etc…); * Patient with prostate cancer not candidate for radical prostatectomy and/or unable to benefit from surgery * Freedom privated patient * Patient under legal protection or unable to express its own consent * Known contraindication to radiopharmaceuticals and / or excipients ……